Literature DB >> 24510628

Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases?

Panagiotis Anagnostis1, Zoe A Efstathiadou, Maria Charizopoulou, Despina Selalmatzidou, Eleni Karathanasi, Maria Poulasouchidou, Marina Kita.   

Abstract

Several studies have shown that acromegaly is associated with increased psychological morbidity. However, it is not known whether this is attributed to acromegaly per se or to its chronicity as a debilitating disease affecting quality of life (QoL). The aim of this study was to assess psychological profile in acromegalics compared with those suffering from other serious chronic diseases and healthy controls. Secondary end points were QoL assessment and its association with mood disturbances. Comparative, cross-sectional study conducted in Northern Greece (2011-2012). The Greek versions of the Profile of Mood States (POMS) and AcroQoL questionnaires were used to assess psychological status and QoL, respectively. Forty acromegalics, 40 age- and sex-matched people with other chronic diseases and 80 healthy controls were included. No significant differences were identified between acromegalics and those suffering from other chronic diseases, regarding tension, anger, depression, confusion, fatigue and vigor. Compared with healthy controls, acromegalics suffered more from depression and anger, which remained significant after controlling for age, gender and marital status (p = 0.003 and p = 0.048, respectively). Negative predictors were female gender, macroadenomas and radiotherapy. AcroQoL scores were negatively associated with POMS subscales. Males had better QoL than females. Other than a negative association between AcroQoL-relationships subscale and disease duration, no association with other parameters was observed. Acromegaly has a negative impact on psychological status, which is worse than that of general population, but comparable to other chronic diseases. Mood disturbances are associated with impaired QoL, mainly in females and those with longer disease duration.

Entities:  

Mesh:

Year:  2014        PMID: 24510628     DOI: 10.1007/s12020-014-0166-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  35 in total

1.  Validation of POMS questionnaire in postmenopausal women.

Authors:  Kathleen W Wyrwich; Holly Yu
Journal:  Qual Life Res       Date:  2011-01-29       Impact factor: 4.147

2.  Acromegaly: presentation, morbidity and treatment outcomes at a single centre.

Authors:  P Anagnostis; Z A Efstathiadou; S A Polyzos; F Adamidou; A Slavakis; M Sapranidis; I D Litsas; S Katergari; D Selalmatzidou; M Kita
Journal:  Int J Clin Pract       Date:  2011-06-16       Impact factor: 2.503

3.  Acromegaly and depression.

Authors:  A Margo
Journal:  Br J Psychiatry       Date:  1981-11       Impact factor: 9.319

4.  Non-functioning pituitary adenomas: a single center experience.

Authors:  P Anagnostis; F Adamidou; S A Polyzos; Z Efstathiadou; A Panagiotou; M Kita
Journal:  Exp Clin Endocrinol Diabetes       Date:  2011-01-24       Impact factor: 2.949

5.  Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study.

Authors:  C Sardella; M Lombardi; G Rossi; C Cosci; S Brogioni; I Scattina; S M Webb; M Gasperi; E Martino; F Bogazzi
Journal:  J Endocrinol Invest       Date:  2010-01       Impact factor: 4.256

6.  Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly.

Authors:  Shih-Che Hua; Yuan-Horng Yan; Tien-Chun Chang
Journal:  Eur J Endocrinol       Date:  2006-12       Impact factor: 6.664

7.  Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly.

Authors:  José Leon-Carrion; Juan Francisco Martin-Rodriguez; Ainara Madrazo-Atutxa; Alfonso Soto-Moreno; Eva Venegas-Moreno; Elena Torres-Vela; Pedro Benito-López; Maria Angeles Gálvez; Francisco J Tinahones; Alfonso Leal-Cerro
Journal:  J Clin Endocrinol Metab       Date:  2010-06-16       Impact factor: 5.958

8.  Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance.

Authors:  Maria P Matta; Elisabeth Couture; Laurent Cazals; Delphine Vezzosi; Antoine Bennet; Philippe Caron
Journal:  Eur J Endocrinol       Date:  2008-03       Impact factor: 6.664

9.  Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed.

Authors:  Tirissa J Reid; Kalmon D Post; Jeffrey N Bruce; M Nabi Kanibir; Carlos M Reyes-Vidal; Pamela U Freda
Journal:  Clin Endocrinol (Oxf)       Date:  2009-05-16       Impact factor: 3.478

10.  Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly.

Authors:  Agatha A van der Klaauw; Nienke R Biermasz; Hendrieke C Hoftijzer; Alberto M Pereira; Johannes A Romijn
Journal:  Clin Endocrinol (Oxf)       Date:  2008-07-01       Impact factor: 3.478

View more
  12 in total

1.  Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire.

Authors:  Silvia Vandeva; Maria Yaneva; Emil Natchev; Atanaska Elenkova; Krasimir Kalinov; Sabina Zacharieva
Journal:  Endocrine       Date:  2015-01-06       Impact factor: 3.633

2.  The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL.

Authors:  Kenichi Yoshida; Hidenori Fukuoka; Ryusaku Matsumoto; Hironori Bando; Kentaro Suda; Hitoshi Nishizawa; Genzo Iguchi; Wataru Ogawa; Susan M Webb; Yutaka Takahashi
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

3.  Quality of Life in Patients with Acromegaly - A Romanian Single Center Cross-Sectional Study.

Authors:  C L Scânteie; D C Leucuţa; C M V Ghervan
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

4.  Stigma and unhealthy psychological characteristics in patients with acromegaly: A cross-sectional study and identification of the associated factors.

Authors:  Yanqing Li; Xiaomei Zhang; Jiajia Zhang; Dandan Zhang; Ya Wang; Yingqian Zhu; Xiuqun Xu
Journal:  Acta Neurochir (Wien)       Date:  2022-05-21       Impact factor: 2.816

Review 5.  Cognitive-behavioral therapy improves the quality of life of patients with acromegaly.

Authors:  Lia Silvia Kunzler; Luciana Ansaneli Naves; Luiz Augusto Casulari
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

6.  Health Outcomes in Acromegaly: Depression and Anxiety are Promising Targets for Improving Reduced Quality of Life.

Authors:  Victor Jacobus Geraedts; Christina Dimopoulou; Matthias Auer; Jochen Schopohl; Günter Karl Stalla; Caroline Sievers
Journal:  Front Endocrinol (Lausanne)       Date:  2015-01-06       Impact factor: 5.555

7.  Higher Income and Integration into the Workforce Are the Main Factors Associated with Quality of Life in Acromegalic Patients in Northeastern Brazil.

Authors:  Adriana Maria GuimarãesSá; Pedro Antônio Muniz Ferreira; Marinilde Teles Souza; Gilvan Cortês Nascimento; Sabrina da Silva Pereira Damianse; Viviane Chaves de Carvalho Rocha; Manuel Dos Santos Faria; Adalgisa de Souza Paiva Ferreira
Journal:  Int J Endocrinol       Date:  2018-02-27       Impact factor: 3.257

Review 8.  Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters.

Authors:  Victor J Geraedts; Cornelie D Andela; Günter K Stalla; Alberto M Pereira; Wouter R van Furth; Caroline Sievers; Nienke R Biermasz
Journal:  Front Endocrinol (Lausanne)       Date:  2017-03-03       Impact factor: 5.555

9.  Health-related Quality of Life in Acromegaly Patients: Results from Generic and Disease-specific Questionnaires.

Authors:  Bruno de A Oliveira; Bruna Araújo; Tainá M Dos Santos; Bárbara R Ongaratti; Carolina G S Leães Rech; Nelson P Ferreira; Júlia F S Pereira-Lima; Miriam da C Oliveira
Journal:  Indian J Endocrinol Metab       Date:  2020-11-09

10.  Differences in quality of life between genders in acromegaly.

Authors:  Daniel Ballesteros-Herrera; Paulina Briseño-Hernández; Rodrigo Pérez-Esparza; Lesly A Portocarrero-Ortiz
Journal:  Endocrinol Diabetes Metab       Date:  2021-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.